Neal JW. Flaviviruses are neurotropic, but how do they invade the CNS? J Infect. 2014;69(3):203–15.
Article
CAS
PubMed
Google Scholar
Domingues RB, et al. Involvement of the central nervous system in patients with dengue virus infection. J Neurol Sci. 2008;267(1–2):36–40.
Article
PubMed
Google Scholar
Puerta-Guardo H, et al. Flavivirus NS1 triggers tissue-specific vascular endothelial dysfunction reflecting disease tropism. Cell Rep. 2019;26(6):1598–613.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chao CH, et al. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage. PLoS Pathog. 2019;15(4):e1007625.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guzman MG, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(12 Suppl):S7-16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vasilakis N, et al. Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health. Nat Rev Microbiol. 2011;9(7):532–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Heinz FX, Stiasny K. Flaviviruses and flavivirus vaccines. Vaccine. 2012;30(29):4301–6.
Article
CAS
PubMed
Google Scholar
Perera-Lecoin M, et al. Flavivirus entry receptors: an update. Viruses. 2013;6(1):69–88.
Article
PubMed
PubMed Central
CAS
Google Scholar
Meertens L, et al. Axl mediates ZIKA virus entry in human glial cells and modulates innate immune responses. Cell Rep. 2017;18(2):324–33.
Article
CAS
PubMed
Google Scholar
Richard AS, et al. AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses. Proc Natl Acad Sci USA. 2017;114(8):2024–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yun SI, Lee YM. Early events in Japanese encephalitis virus infection: viral entry. Pathogens. 2018;7(3):68.
Article
CAS
PubMed Central
Google Scholar
Apte-Sengupta S, Sirohi D, Kuhn RJ. Coupling of replication and assembly in flaviviruses. Curr Opin Virol. 2014;9:134–42.
Article
CAS
PubMed
Google Scholar
Lindenbach BD. Virion assembly and release. Curr Top Microbiol Immunol. 2013;369:199–218.
CAS
PubMed
PubMed Central
Google Scholar
Zhang Y, et al. Conformational changes of the flavivirus E glycoprotein. Structure. 2004;12(9):1607–18.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stettler K, et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science. 2016;353(6301):823–6.
Article
CAS
PubMed
Google Scholar
Zhang S, et al. Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III. Virology. 2010;403(1):85–91.
Article
CAS
PubMed
Google Scholar
Huerta V, et al. Characterization of the interaction of domain III of the envelope protein of dengue virus with putative receptors from CHO cells. Virus Res. 2008;137(2):225–34.
Article
CAS
PubMed
Google Scholar
Gallichotte EN, et al. CD-loop extension in Zika virus envelope protein key for stability and pathogenesis. J Infect Dis. 2017;216(10):1196–204.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tsai WY, et al. C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins. PLoS One. 2012;7(12):e52600.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dai L, et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe. 2016;19(5):696–704.
Article
CAS
PubMed
Google Scholar
Luca VC, et al. Crystal structure of the Japanese encephalitis virus envelope protein. J Virol. 2012;86(4):2337–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Despres P, et al. The 15 amino acid residues preceding the amino terminus of the envelope protein in the yellow fever virus polyprotein precursor act as a signal peptide. Virus Res. 1990;16(1):59–75.
Article
CAS
PubMed
Google Scholar
Hsieh SC, Tsai WY, Wang WK. The length of and nonhydrophobic residues in the transmembrane domain of dengue virus envelope protein are critical for its retention and assembly in the endoplasmic reticulum. J Virol. 2010;84(9):4782–97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Purdy DE, Chang GJ. Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein. Virology. 2005;333(2):239–50.
Article
CAS
PubMed
Google Scholar
Johnson AJ, Guirakhoo F, Roehrig JT. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology. 1994;203(2):241–9.
Article
CAS
PubMed
Google Scholar
Monath TP, et al. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J Virol. 2002;76(4):1932–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Goo L, et al. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions. Nat Microbiol. 2019;4(1):71–7.
Article
CAS
PubMed
Google Scholar
Annamalai AS, et al. Zika virus encoding nonglycosylated envelope protein is attenuated and defective in neuroinvasion. J Virol. 2017. https://doi.org/10.1128/JVI.01348-17.
Article
PubMed
PubMed Central
Google Scholar
Goto A, et al. A BHK-21 cell culture-adapted tick-borne encephalitis virus mutant is attenuated for neuroinvasiveness. Vaccine. 2003;21(25–26):4043–51.
Article
CAS
PubMed
Google Scholar
Konishi E, Mason PW. Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J Virol. 1993;67(3):1672–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lorenz IC, et al. Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol. 2002;76(11):5480–91.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gallichotte EN, et al. Role of Zika virus envelope protein domain III as a target of human neutralizing antibodies. mBio. 2019. https://doi.org/10.1128/mBio.01485-19.
Article
PubMed
PubMed Central
Google Scholar
Mary JA, et al. A synthetic peptide derived from domain III envelope glycoprotein of Dengue virus induces neutralizing antibody. Virus Genes. 2018;54(1):25–32.
Article
CAS
PubMed
Google Scholar
Bai F, et al. Antiviral peptides targeting the west nile virus envelope protein. J Virol. 2007;81(4):2047–55.
Article
CAS
PubMed
Google Scholar
Kuhn RJ, et al. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell. 2002;108(5):717–25.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rodenhuis-Zybert IA, Wilschut J, Smit JM. Dengue virus life cycle: viral and host factors modulating infectivity. Cell Mol Life Sci. 2010;67(16):2773–86.
Article
CAS
PubMed
Google Scholar
Chen Y, et al. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med. 1997;3(8):866–71.
Article
CAS
PubMed
Google Scholar
Wu S, et al. Heparin sulfate is the attachment factor of duck Tembus virus on both BHK21 and DEF cells. Virol J. 2019;16(1):134.
Article
PubMed
PubMed Central
CAS
Google Scholar
Aliyu IA, et al. Annexin II as a dengue virus serotype 2 interacting protein mediating virus interaction on Vero cells. Viruses. 2019;11(4):335.
Article
CAS
PubMed Central
Google Scholar
Kalia M, et al. Japanese encephalitis virus infects neuronal cells through a clathrin-independent endocytic mechanism. J Virol. 2013;87(1):148–62.
Article
CAS
PubMed
PubMed Central
Google Scholar
Acosta EG, Castilla V, Damonte EB. Functional entry of dengue virus into Aedes albopictus mosquito cells is dependent on clathrin-mediated endocytosis. J Gen Virol. 2008;89(Pt 2):474–84.
Article
CAS
PubMed
Google Scholar
Sirohi D, et al. The 38 A resolution cryo-EM structure of Zika virus. Science. 2016;352(6284):467–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Roehrig JT, et al. Mutation of the dengue virus type 2 envelope protein heparan sulfate binding sites or the domain III lateral ridge blocks replication in Vero cells prior to membrane fusion. Virology. 2013;441(2):114–25.
Article
CAS
PubMed
Google Scholar
Fontes-Garfias CR, et al. Functional analysis of glycosylation of Zika virus envelope protein. Cell Rep. 2017;21(5):1180–90.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mondotte JA, et al. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. J Virol. 2007;81(13):7136–48.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang P, et al. DC-SIGN as an attachment factor mediates Japanese encephalitis virus infection of human dendritic cells via interaction with a single high-mannose residue of viral E glycoprotein. Virology. 2016;488:108–19.
Article
CAS
PubMed
Google Scholar
Hanna SL, et al. N-linked glycosylation of west nile virus envelope proteins influences particle assembly and infectivity. J Virol. 2005;79(21):13262–74.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lin SR, et al. The helical domains of the stem region of dengue virus envelope protein are involved in both virus assembly and entry. J Virol. 2011;85(10):5159–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen L, et al. Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses. Antiviral Res. 2017;141:140–9.
Article
CAS
PubMed
Google Scholar
Yang J, et al. Envelope protein mutations L107F and E138K are important for neurovirulence attenuation for Japanese encephalitis virus SA14-14-2 strain. Viruses. 2017;9(1):20.
Article
PubMed Central
CAS
Google Scholar
Zhao Z, et al. Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by using a stable, full-length, infectious cDNA clone. J Gen Virol. 2005;86(Pt 8):2209–20.
Article
CAS
PubMed
Google Scholar
Zheng X, et al. Acidity/alkalinity of Japanese encephalitis virus E protein residue 138 alters neurovirulence in mice. J Virol. 2018. https://doi.org/10.1128/JVI.00108-18.
Article
PubMed
PubMed Central
Google Scholar
Liu X, et al. The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism. Protein Cell. 2019;10(2):149–53.
Article
CAS
PubMed
Google Scholar
Lee E, Lobigs M. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J Virol. 2000;74(19):8867–75.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hurrelbrink RJ, McMinn PC. Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein. J Virol. 2001;75(16):7692–702.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ryman KD, et al. Mutation in a 17D–204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Virology. 1998;244(1):59–65.
Article
CAS
PubMed
Google Scholar
Huang YJ, et al. Mutagenesis analysis of T380R mutation in the envelope protein of yellow fever virus. Virol J. 2014;11:60.
Article
PubMed
PubMed Central
CAS
Google Scholar
Zhao D, et al. Identification of determinants that mediate binding between Tembusu virus and the cellular receptor heat shock protein A9. J Vet Sci. 2018;19(4):528–35.
Article
PubMed
PubMed Central
Google Scholar
Yang L, et al. Substantial attenuation of virulence of Tembusu virus strain PS is determined by an arginine at residue 304 of the envelope protein. J Virol. 2021;95(6):e02331-20.
Article
PubMed
PubMed Central
Google Scholar
Sun M, et al. Basic amino acid substitution at residue 367 of the envelope protein of Tembusu virus plays a critical role in pathogenesis. J Virol. 2020;94(8):e02011-19.
Article
PubMed
PubMed Central
Google Scholar
Liu H, et al. Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virus. J Virol. 2015;89(10):5668–86.
Article
CAS
PubMed
PubMed Central
Google Scholar
Watterson D, Kobe B, Young PR. Residues in domain III of the dengue virus envelope glycoprotein involved in cell-surface glycosaminoglycan binding. J Gen Virol. 2012;93(Pt 1):72–82.
Article
CAS
PubMed
Google Scholar
Zhang F, Ren S, Zuo Y. DC-SIGN, DC-SIGNR and LSECtin: C-type lectins for infection. Int Rev Immunol. 2014;33(1):54–66.
Article
CAS
PubMed
Google Scholar
Tassaneetrithep B, et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med. 2003;197(7):823–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu K, et al. mosGCTL-7, a C-Type Lectin Protein, Mediates Japanese Encephalitis Virus Infection in Mosquitoes. J Virol. 2017. https://doi.org/10.1128/JVI.01348-16.
Article
PubMed
PubMed Central
Google Scholar
Alen MM, et al. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection. Antiviral Res. 2012;96(3):280–7.
Article
CAS
PubMed
Google Scholar
Routhu NK, et al. Glycosylation of Zika virus is important in host-virus interaction and pathogenic potential. Int J Mol Sci. 2019;20(20):5206.
Article
CAS
PubMed Central
Google Scholar
Zhang S, et al. Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and effectively prevents maternal to fetal transmission of Zika virus. Antiviral Res. 2019;169:104547.
Article
CAS
PubMed
Google Scholar
Bos S, et al. The envelope residues E152/156/158 of Zika virus influence the early stages of virus infection in human cells. Cells. 2019;8(11):1444.
Article
CAS
PubMed Central
Google Scholar
Scherwitzl I, Mongkolsapaja J, Screaton G. Recent advances in human flavivirus vaccines. Curr Opin Virol. 2017;23:95–101.
Article
CAS
PubMed
Google Scholar
Sun L, et al. Adaptation and attenuation of duck Tembusu virus strain Du/CH/LSD/110128 following serial passage in chicken embryos. Clin Vaccine Immunol. 2014;21(8):1046–53.
Article
PubMed
PubMed Central
CAS
Google Scholar
Edelman R, et al. A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. J Infect Dis. 1994;170(6):1448–55.
Article
CAS
PubMed
Google Scholar
Basset J, et al. A molecular determinant of west nile virus secretion and morphology as a target for viral attenuation. J Virol. 2020. https://doi.org/10.1128/JVI.00086-20.
Article
PubMed
PubMed Central
Google Scholar
Xin YY, et al. Safety of a live-attenuated Japanese encephalitis virus vaccine (SA14-14-2) for children. Am J Trop Med Hyg. 1988;39(2):214–7.
Article
CAS
PubMed
Google Scholar
Hennessy S, et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet. 1996;347(9015):1583–6.
Article
CAS
PubMed
Google Scholar
Mueller DS, et al. Histidine protonation and the activation of viral fusion proteins. Biochem Soc Trans. 2008;36(Pt 1):43–5.
Article
CAS
PubMed
Google Scholar
Fritz R, Stiasny K, Heinz FX. Identification of specific histidines as pH sensors in flavivirus membrane fusion. J Cell Biol. 2008;183(2):353–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Oliphant T, et al. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein. J Virol. 2006;80(24):12149–59.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nivarthi UK, et al. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination. J Virol. 2017. https://doi.org/10.1128/JVI.02041-16.
Article
PubMed
PubMed Central
Google Scholar
McMinn PC, et al. Murray valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice. Virology. 1995;211(1):10–20.
Article
CAS
PubMed
Google Scholar
Bressanelli S, et al. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 2004;23(4):728–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu Q, et al. Identification of heat shock protein A9 as a Tembusu virus binding protein on DF-1 cells. Virus Res. 2017;227:110–4.
Article
CAS
PubMed
Google Scholar
Kanai R, et al. Crystal structure of west nile virus envelope glycoprotein reveals viral surface epitopes. J Virol. 2006;80(22):11000–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li C, et al. Inhibition of Japanese encephalitis virus entry into the cells by the envelope glycoprotein domain III (EDIII) and the loop3 peptide derived from EDIII. Antiviral Res. 2012;94(2):179–83.
Article
CAS
PubMed
Google Scholar
Hung JJ, et al. An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells. J Virol. 2004;78(1):378–88.
Article
CAS
PubMed
PubMed Central
Google Scholar
van der Most RG, Corver J, Strauss JH. Mutagenesis of the RGD motif in the yellow fever virus 17D envelope protein. Virology. 1999;265(1):83–95.
Article
PubMed
CAS
Google Scholar
Lobigs M, et al. Host cell selection of Murray Valley encephalitis virus variants altered at an RGD sequence in the envelope protein and in mouse virulence. Virology. 1990;176(2):587–95.
Article
CAS
PubMed
Google Scholar
Guerrero CA, et al. Integrin alpha(v)beta(3) mediates rotavirus cell entry. Proc Natl Acad Sci USA. 2000;97(26):14644–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gavrilovskaya IN, et al. beta3 Integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci USA. 1998;95(12):7074–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee JW, Chu JJ, Ng ML. Quantifying the specific binding between West Nile virus envelope domain III protein and the cellular receptor alphaVbeta3 integrin. J Biol Chem. 2006;281(3):1352–60.
Article
CAS
PubMed
Google Scholar
Hilgard P, Stockert R. Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology. 2000;32(5):1069–77.
Article
CAS
PubMed
Google Scholar
Germi R, et al. Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology. 2002;292(1):162–8.
Article
CAS
PubMed
Google Scholar
Volk DE, et al. Structure of yellow fever virus envelope protein domain III. Virology. 2009;394(1):12–8.
Article
CAS
PubMed
Google Scholar
Frei JC, et al. Engineered dengue virus domain III proteins elicit cross-neutralizing antibody responses in mice. J Virol. 2018. https://doi.org/10.1128/JVI.01023-18.
Article
PubMed
PubMed Central
Google Scholar
Chambers TJ, Nickells M. Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone. J Virol. 2001;75(22):10912–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hahn CS, et al. Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it. Proc Natl Acad Sci USA. 1987;84(7):2019–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nickells M, Chambers TJ. Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice. J Virol. 2003;77(22):12232–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee E, Lobigs M. E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence. J Virol. 2008;82(12):6024–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hackett BA, Cherry S. Flavivirus internalization is regulated by a size-dependent endocytic pathway. Proc Natl Acad Sci USA. 2018;115(16):4246–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fernandez-Garcia MD, et al. Vaccine and wild-type strains of yellow fever virus engage distinct entry mechanisms and differentially stimulate antiviral immune responses. mBio. 2016;7(1):e01956-15.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hileman RE, et al. Glycosaminoglycan-protein interactions: definition of consensus sites in glycosaminoglycan binding proteins. BioEssays. 1998;20(2):156–67.
Article
CAS
PubMed
Google Scholar
Boigard H, et al. Zika virus-like particle (VLP) based vaccine. PLoS Negl Trop Dis. 2017;11(5):e0005608.
Article
PubMed
PubMed Central
CAS
Google Scholar
Khromykh AA, Varnavski AN, Westaway EG. Encapsidation of the flavivirus kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans. J Virol. 1998;72(7):5967–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lu CY, et al. Single-round infectious particle antiviral screening assays for the Japanese encephalitis virus. Viruses. 2017;9(4):76.
Article
PubMed Central
CAS
Google Scholar
de Wispelaere M, Yang PL. Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly. J Virol. 2012;86(13):7072–83.
Article
PubMed
PubMed Central
CAS
Google Scholar
He Y, et al. Genetically stable reporter virus, subgenomic replicon and packaging system of duck Tembusu virus based on a reverse genetics system. Virology. 2019;533:86–92.
Article
CAS
PubMed
Google Scholar
Kaufmann B, et al. Capturing a flavivirus pre-fusion intermediate. PLoS Pathog. 2009;5(11):e1000672.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lv J, et al. The neutralizing antibody response elicited by Tembusu virus is affected dramatically by a single mutation in the stem region of the envelope protein. Front Microbiol. 2020;11:585194.
Article
PubMed
PubMed Central
Google Scholar
Khetarpal N, Khanna I. Dengue fever: causes, complications, and vaccine strategies. J Immunol Res. 2016;2016:6803098.
Article
PubMed
PubMed Central
CAS
Google Scholar
Rey FA, et al. The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design. EMBO Rep. 2018;19(2):206–24.
Article
CAS
PubMed
Google Scholar
Berneck BS, et al. A recombinant Zika virus envelope protein with mutations in the conserved fusion loop leads to reduced antibody cross-reactivity upon vaccination. Vaccines Basel. 2020;8(4):603.
Article
CAS
PubMed Central
Google Scholar
Zhao H, et al. Structural basis of Zika virus-specific antibody protection. Cell. 2016;166(4):1016–27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhao H, et al. Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge. J Exp Med. 2020. https://doi.org/10.1084/jem.20191792.
Article
PubMed
PubMed Central
Google Scholar
Wu Y, et al. Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III. Emerg Microbes Infect. 2017;6(10):e89.
CAS
PubMed
PubMed Central
Google Scholar
Oliphant T, et al. Induction of epitope-specific neutralizing antibodies against West Nile virus. J Virol. 2007;81(21):11828–39.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dejnirattisai W, et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat Immunol. 2015;16(2):170–7.
Article
CAS
PubMed
Google Scholar
Barba-Spaeth G, et al. Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature. 2016;536(7614):48–53.
Article
CAS
PubMed
Google Scholar
Sapparapu G, et al. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature. 2016;540(7633):443–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Q, et al. Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus. Sci Transl Med. 2016;8(369):369ra179.
Article
PubMed
CAS
Google Scholar
Cabral-Miranda G, et al. Zika virus-derived E-DIII protein displayed on immunologically optimized VLPs induces neutralizing antibodies without causing enhancement of dengue virus infection. Vaccines Basel. 2019;7(3):72.
Article
CAS
PubMed Central
Google Scholar
Slon-Campos JL, et al. A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection. Nat Immunol. 2019;20(10):1291–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hurtado-Monzon AM, et al. The role of anti-flavivirus humoral immune response in protection and pathogenesis. Rev Med Virol. 2020;30(4):e2100.
Article
CAS
PubMed
Google Scholar
Navarro-Sanchez E, et al. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 2003;4(7):723–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Taguwa S, et al. Defining Hsp70 subnetworks in dengue virus replication reveals key vulnerability in flavivirus infection. Cell. 2015;163(5):1108–23.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cabrera-Hernandez A, et al. Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70. J Med Virol. 2007;79(4):386–92.
Article
PubMed
Google Scholar
Pujhari S, et al. Heat shock protein 70 (Hsp70) mediates Zika virus entry, replication, and egress from host cells. Emerg Microbes Infect. 2019;8(1):8–16.
Article
CAS
PubMed
PubMed Central
Google Scholar
Das S, et al. Heat shock protein 70 on Neuro2a cells is a putative receptor for Japanese encephalitis virus. Virology. 2009;385(1):47–57.
Article
CAS
PubMed
Google Scholar
Nain M, et al. GRP78 is an important host factor for Japanese encephalitis virus entry and replication in mammalian cells. J Virol. 2017;91(6):7. https://doi.org/10.1128/JVI.02274-16.
Article
Google Scholar
Upanan S, Kuadkitkan A, Smith DR. Identification of dengue virus binding proteins using affinity chromatography. J Virol Methods. 2008;151(2):325–8.
Article
CAS
PubMed
Google Scholar
Wang Y, Li Y, Ding T. Heat shock protein 90beta in the Vero cell membrane binds Japanese encephalitis virus. Int J Mol Med. 2017;40(2):474–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hershkovitz O, et al. NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells. J Immunol. 2009;183(4):2610–21.
Article
CAS
PubMed
Google Scholar
Zhu Z, et al. Zika virus targets glioblastoma stem cells through a SOX2-integrin alphavbeta5 axis. Cell Stem Cell. 2020;26(2):187-204e10.
Article
CAS
PubMed
Google Scholar
Meertens L, et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell Host Microbe. 2012;12(4):544–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Niu J, et al. TIM-1 promotes Japanese encephalitis virus entry and infection. Viruses. 2018;10(11):630.
Article
CAS
PubMed Central
Google Scholar
Carnec X, et al. The phosphatidylserine and phosphatidylethanolamine receptor CD300a binds dengue virus and enhances infection. J Virol. 2016;90(1):92–102.
Article
CAS
PubMed
Google Scholar
Tan CW, et al. Cell surface alpha2,3-linked sialic acid facilitates Zika virus internalization. Emerg Microbes Infect. 2019;8(1):426–37.
Article
CAS
PubMed
PubMed Central
Google Scholar
Miller JL, et al. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog. 2008;4(2):17.
Article
CAS
Google Scholar
Sharma A, et al. Prohibitin 1/2 mediates Dengue-3 entry into human neuroblastoma (SH-SY5Y) and microglia (CHME-3) cells. J Biomed Sci. 2020;27(1):55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thepparit C, Smith DR. Serotype-specific entry of dengue virus into liver cells: identification of the 37-kilodalton/67-kilodalton high-affinity laminin receptor as a dengue virus serotype 1 receptor. J Virol. 2004;78(22):12647–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mukherjee S, et al. PLVAP and GKN3 are two critical host cell receptors which facilitate Japanese encephalitis virus entry into neurons. Sci Rep. 2018;8(1):11784.
Article
PubMed
PubMed Central
CAS
Google Scholar